Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
New technologies are rapidly reshaping health care. However, their effect on drug development to date generally has been limited.
To evaluate disease modeling and simulation, alternative study design, novel objective measures, virtual research visits, and enhanced participant engagement and to examine their potential effects as methods and tools on clinical trials.
We conducted a systematic search of relevant terms on PubMed (disease modeling and clinical trials; adaptive design, clinical trials, and neurology; Internet, clinical trials, and neurology; and telemedicine, clinical trials, and neurology), references of previous publications, and our files. The search encompassed articles published from January 1, 2000, through November 30, 2014, and produced 7976 articles, of which 22 were determined to be relevant and are included in this review.
Few of these new methods and technologies have been applied to neurology clinical trials. Clinical outcomes, including cognitive and stroke outcomes, increasingly are captured remotely. Other therapeutic areas have successfully implemented many of these tools and technologies, including web-enabled clinical trials.
Conclusions and Relevance
Increased use of new tools and approaches in future clinical trials can enhance the design, improve the assessment, and engage participants in the evaluation of novel therapies for neurologic disorders.
Dorsey ER, Venuto C, Venkataraman V, Harris DA, Kieburtz K. Novel Methods and Technologies for 21st-Century Clinical Trials: A Review. JAMA Neurol. 2015;72(5):582–588. doi:10.1001/jamaneurol.2014.4524
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: